Patient Safety Risk / en Sat, 09 Aug 2025 21:42:18 -0500 Mon, 14 Jul 25 15:14:11 -0500 AHA resource provides strategies, best practices on sepsis care from Ochsner Health /news/headline/2025-07-14-aha-resource-provides-strategies-best-practices-sepsis-care-ochsner-health <p>To help hospitals across the country improve sepsis care, the Centers for Disease Control and Prevention created the Hospital Sepsis Program Core Elements, consisting of seven strategies designed to enhance early detection and treatment. The AHA’s Living Learning Network recently visited Ochsner Health, a system at the forefront of implementing this framework, highlighting how leadership, systemwide coordination and team-based practices are improving sepsis outcomes. <a href="/center/living-learning-network/revolutionizing-sepsis-management" title="sepsis info"><strong>LEARN MORE</strong></a> </p> Mon, 14 Jul 2025 15:14:11 -0500 Patient Safety Risk FDA alerts of risk with Calyxo aspiration systems /news/headline/2025-03-20-fda-alerts-risk-calyxo-aspiration-systems <p>The Food and Drug Administration today issued an <a href="https://www.fda.gov/medical-devices/medical-device-recalls/early-alert-aspiration-system-issue-calyxo" target="_blank">alert</a> on a potentially high-risk issue with Calyxo CVAC Aspiration Systems. In patients who have thick fluid in their kidneys at the start of the procedure, the system can cause reduced fluid overflow, potentially leading to excessive pressure in the kidneys. Serious death or injury could occur if the increased pressure is not addressed. Calyxo has reported one death associated with the issue. </p> Thu, 20 Mar 2025 14:39:52 -0500 Patient Safety Risk AHA podcast: A Tiered System of Safety — Committing to Zero Harm with WellSpan Health /news/headline/2025-02-19-aha-podcast-tiered-system-safety-committing-zero-harm-wellspan-health <p>In this conversation, Carlos Roberts, M.D., urogynecologist, vice president and chief medical officer of the Women and Children service line at WellSpan Health, discusses the organization's commitment to zero harm, its innovative tier structure for daily safety huddles, and its fostered culture of continuous improvement and celebration of patient safety. <a href="/advancing-health-podcast/2025-02-19-tiered-system-safety-committing-zero-harm-wellspan-health" title="POD LINK"><strong>LISTEN NOW</strong></a><strong> </strong></p><div></div> Wed, 19 Feb 2025 14:48:56 -0600 Patient Safety Risk AHA podcast: To Mitigate and Prevent — CommonSpirit Health's Transparent Culture and Error Reporting Toolkit /news/headline/2024-12-04-aha-podcast-mitigate-and-prevent-commonspirit-healths-transparent-culture-and-error-reporting-toolkit <p>In this “Safety Speaks” conversation, CommonSpirit Health's Beth Miller, system director, patient safety-performance improvement, and Austin Peterson, system director, patient harm prevention, discuss how safety transparency benefits both patients and providers, and how a CommonSpirit Health toolkit can help organizations lead the way in error reporting and patient safety. <a href="/advancing-health-podcast/2024-12-04-mitigate-and-prevent-commonspirit-healths-transparent-culture-and-error-reporting-toolkit"><strong>LISTEN NOW</strong></a></p><div></div> Wed, 04 Dec 2024 16:06:58 -0600 Patient Safety Risk Member Report: Quality Trends and the AHA Patient Safety Initiative /member-report-quality-trends-and-aha-patient-safety-initiative <div class="row"><div class="col-md-5"><img src="/sites/default/files/2024-03/Quality-as-defined-by-members-700-532.jpg" alt="Quality as Defined by Members Report" width="700" height="532"></div><ul><li>The Association (AHA) presents insights from the Quality Collective (QC), a collaborative platform addressing health care quality improvement challenges amid the COVID-19 pandemic.</li><li>QC members note a dynamic shift in the definition of quality, with 60% experiencing changes over the past three years.</li><li>Clinical strengths include patient safety, infection prevention and emergency preparedness, while areas for improvement include population health management and health equity.</li><li>QC outlines priorities for the future, emphasizing a commitment to safe, timely, effective, equitable, patient-centered and affordable care.</li><li>Anticipating the increasing role of technology, members foresee the prevalence of artificial intelligence in disinfection practices.</li></ul><p>The AHA introduces the Patient Safety Initiative, building on QC success, to empower hospitals in national health care safety discussions. The initiative aims to enhance engagement, public trust and data accuracy while reducing preventable harms and inequities. AHA, with extensive membership, leads the initiative through research, collaboration and data sharing, reinforcing its commitment and leadership in the health care field.</p><p>The AHA acknowledges hospitals' commitment to providing safe, high-quality care amid the expanded definition of quality post-COVID-19. The QC, launched as a collaborative platform, engaged leaders in quality improvement over three months. Members focused on co-designing strategies to address current needs and shape the future trajectory of quality standards. The report highlights successes, innovative solutions and a redefined culture rooted in quality and performance. The AHA expresses gratitude to participants for their contributions in fostering a just society of healthy communities.</p></div> Wed, 10 Jul 2024 12:45:00 -0500 Patient Safety Risk FDA withdraws accelerated approval of myeloma drug /news/headline/2024-02-26-fda-withdraws-accelerated-approval-myeloma-drug <p>The Food and Drug Administration Feb. 23 withdrew <a href="https://www.fda.gov/drugs/drug-safety-and-availability/fda-issues-final-decision-withdraw-approval-pepaxto-melphalan-flufenamide" target="_blank">approval</a> of Pepaxto (melphalan flufenamide), a drug once used with dexamethasone to treat certain U.S. patients with multiple myeloma, because a post-approval trial did not show it safe or effective. This is the first time the agency has used procedures amended under the Food and Drug Omnibus Report Act of 2022 to withdraw accelerated approval of a drug. The drug is not currently marketed in the U.S., FDA said.</p> Mon, 26 Feb 2024 14:15:24 -0600 Patient Safety Risk Episode 2: Strategies for Using Cybersecurity to Protect Patient Safety at Rural Hospitals /center/cybersecurity-and-risk-advisory-services/preferred-cybersecurity/bringing-value/ep2-strategies-using-cybersecurity-prot Fri, 01 Sep 2023 11:00:00 -0500 Patient Safety Risk AHA’s Preferred Cybersecurity & Risk Providers Bringing Value Podcast Series /center/cybersecurity-and-risk-advisory-services/preferred-cybersecurity/bringing-value Thu, 31 Aug 2023 14:29:11 -0500 Patient Safety Risk AHA comments on proposed AHRQ initiative to advance patient safety /news/news/2023-01-26-aha-comments-proposed-ahrq-initiative-advance-patient-safety <p>AHA today submitted <a href="/lettercomment/2023-01-26-aha-comments-ahrqs-request-information-creating-nation-al-health-care-system-action-alliance-advance">comments</a> on how the Agency for Healthcare Research and Quality can best support the field in advancing patient safety through an action alliance, which the agency is launching in partnership with health care systems and patient safety advocates. AHA recommends the agency align the alliance’s work with other federal efforts to accelerate patient safety; prioritize resources on addressing the most preventable adverse safety events; engage patients and providers along the full care continuum; and back the alliance with robust logistical support to capture and broadly share important learnings and evidence-based care improvement tools. <br />  </p> Thu, 26 Jan 2023 16:03:00 -0600 Patient Safety Risk FDA announces recall of Abbott imaging catheter /news/headline/2022-05-26-fda-announces-recall-abbott-imaging-catheter <p>Abbott has recalled certain lots of its Dragonfly OpStar imaging catheter because a marker band may separate from the catheter and remain in the patient after use, potentially causing injury, the Food and Drug Administration <a href="https://www.fda.gov/medical-devices/medical-device-recalls/abbott-medical-recalls-dragonfly-opstar-imaging-catheter-potential-loose-catheter-marker-band-may">announced</a> today. The catheter is used for optical coherence tomography of coronary arteries. Five related incidents and one injury have been reported. Health care providers should immediately stop using devices in the affected lots and report any product performance issues to Abbott, FDA said.<br />  </p> Thu, 26 May 2022 16:28:37 -0500 Patient Safety Risk